LXEO ▲ +13.2% - Lexeo Therapeutics, Inc.
$LXEO - Lexeo Therapeutics Announces Positive Interim Phase I/II Data and Regulatory Update for LX2020 in PKP2 Arrhythmogenic Cardiomyopathy and Reports Third Quarter 2026 Financial Results
16-NOV-2026 07:00 AM ET
Share this post
💬 Comments
Loading comments…
Leave a comment
